Vimarsana
Biggest News Aggregation in the World

Page 13 - Sera Prognostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sera Prognostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sera Prognostics Today - Breaking & Trending Today

FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS - Vimarsana News

FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

UnivDatos Market Insights Pvt. Ltd.: Femtech Market to Witness CAGR of 12% (2022-2028) Due to Increasing Digital Health Solutions Worldwide - Vimarsana News

UnivDatos Market Insights Pvt. Ltd.: Femtech Market to Witness CAGR of 12% (2022-2028) Due to Increasing Digital Health Solutions Worldwide

NOIDA, India, Nov. 18, 2022 /PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Femtech Market was valued at 2.8 billion in 2020 and is expected to grow

Femtech Market to Witness CAGR of 12% (2022-2028) Due to Increasing Digital Health Solutions Worldwide - Vimarsana News

Femtech Market to Witness CAGR of 12% (2022-2028) Due to Increasing Digital Health Solutions Worldwide

/PRNewswire/ -- According to a new report published by UnivDatos Markets Insights, the Femtech Market was valued at 2.8 billion in 2020 and is expected to grow...

SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA PREDICTING CLINICAL UTILITY AND COST EFFECTIVENESS OF THE PRETRM® TEST-AND-TREAT STRATEGY ACROSS DIVERSE POPULATIONS - Vimarsana News

SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA PREDICTING CLINICAL UTILITY AND COST EFFECTIVENESS OF THE PRETRM® TEST-AND-TREAT STRATEGY ACROSS DIVERSE POPULATIONS

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

SERA PROGNOSTICS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS - Vimarsana News

SERA PROGNOSTICS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative...